ÂÜÀòÂÒÂ×

Ms. Butitta has more than 25 years of experience informing corporate strategy and business development in the biotechnology and high technology sectors to the Century Board of Directors. Most recently, she served as the Chief Operating Officer and Chief Financial Officer of Kite Pharma where she was responsible for securing over $1 billion in capital and contributed to the extensive growth of the organization. Ms. Butitta was also critical in facilitating the company's acquisition by Gilead Sciences for approximately $11.9 billion in 2017. Prior to Kite Pharma, Ms. Butitta was the Senior Vice President and Chief Financial Officer of NextWave Pharmaceuticals until its acquisition by Pfizer in 2012. She has also held executive leadership roles at Telik, Inc., Connetics Corporation, and InSite Vision Inc. Ms. Butitta is currently an Independent Director at Olema Oncology, Autolus Ltd., and UroGen Pharma. She holds a B.S. in business and accounting from Edgewood College and received her M.B.A. in finance from the University of Wisconsin, Madison.